LeafCann and WardMM Announce Clinical Trial for the Treatment of BPSD
NOVEMBER 29, 2017
eafCann Research and Advisory (LeafCann R&A), announces the signing of a clinical trial agreement with WardMM to sponsor and provide medicinal cannabis extracts for WardMM’s research and development program dedicated to the treatment of behavioural and psychological symptoms of dementia (BPSD).
Atlas Subsidiary enters into JV with LeafCann Group to pursue Medicinal Cannabis License
AUGUST 30, 2017
Expert Clinical Educator Dr. Elise Sullivan Joins LeafCann Research and Advisory as Director of Education & Policy
JULY 11, 2017
Growing cannabis industry buoyed by regulation change
JUNE 15, 2017
Australia's growing medicinal cannabis industry is confident investors will be "more inclined to open their wallets" after Parliament's shock decision to fast track terminally ill patient's access to the drug.
UN Push for Medical Cannabis
MAY 9, 2017
'Studio 10 speaking with Elisabetta Faenza from LeafCann about the campaign to get medical cannabis fully legalised in Australia.
MARCH 12, 2017
'Studio 10 speaking with Elisabetta Faenza from LeafCann about medical cannabis in Australia.'
6PR882 NEWS TALK
MARCH 1, 2017
'There is growing buzz around importation of medicinal cannabis, which has been met with mixed reactions. What does the fledgling local industry have to say?'